Jan Potempa

Dr. Jan Potempa

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
SDStephen S. Dominy
Stephen S. Dominy
CLCasey Lynch
Casey Lynch
FEFlorian Ermini
Florian Ermini
MBMalgorzata Benedyk
Malgorzata Benedyk
AMAgata Marczyk
Agata Marczyk
JPJan Potempa
Jan Potempa
Gingipains from Porphyromonas gingivalis drive Alzheimer’s pathology and can be blocked with small-molecule inhibitors.

31 August 2010 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
NWNatalia Wegner
Natalia Wegner
RWRobin Wait
Robin Wait
ASAneta Sroka
Aneta Sroka
SESigrun Eick
Sigrun Eick
KNKy‐Anh Nguyen
Ky‐Anh Nguyen
PVPatrick J. Venables
Patrick J. Venables
Objective: To investigate protein citrullination by the periodontal pathogen Porphyromonas gingivalis as a potential mechanism for breaking tolerance to citrullinated proteins in rheumatoid arthritis (RA).Methods: The expression of endogenous citrullinated proteins was analyzed by immunoblotting of cell extracts from P gingivalis and 10 other oral bacteria. P gingivalis–knockout strains lacking the bacterial peptidylarginine deiminases (PADs) or gingipains were created to assess the role of these enzymes in citrullination. Citrullination of human fibrinogen and α‐enolase by P gingivalis was studied by incubating live wild‐type and knockout strains with the proteins and analyzing the products by immunoblotting and mass spectrometry.Results: Endogenous protein citrullination was abundant in P gingivalis but lacking in the other oral bacteria. Deletion of the bacterial PAD gene resulted in complete abrogation of protein citrullination. Inactivation of arginine gingipains, but not lysine gingipains, led to decreased citrullination. Incubation of wild‐type P gingivalis with fibrinogen or α‐enolase caused degradation of the proteins and citrullination of the resulting peptides at carboxy‐terminal arginine residues, which were identified by mass spectrometry.Conclusion: Our findings demonstrate that among the oral bacterial pathogens tested, P gingivalis is unique in its ability to citrullinate proteins. We further show that P gingivalis rapidly generates citrullinated host peptides by proteolytic cleavage at Arg‐X peptide bonds by arginine gingipains, followed by citrullination of carboxy‐terminal arginines by bacterial PAD. Our results suggest a novel model where P gingivalis–mediated citrullination of bacterial and host proteins provides a molecular mechanism for generating antigens that drive the autoimmune response in RA.

1 December 2004 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
MSMagdalena Sieprawska-Lupa
Magdalena Sieprawska-Lupa
PMPiotr Mydel
Piotr Mydel
KKKatarzyna Krawczyk
Katarzyna Krawczyk
KWKinga Wójcik
Kinga Wójcik
MPMagdalena Puklo
Magdalena Puklo
JPJan Potempa
Jan Potempa
Cathelicidin LL-37 is one of the few human bactericidal peptides with potent antistaphylococcal activity. In this study we examined the susceptibility of LL-37 to proteolytic degradation by two major proteinases produced by Staphylococcus aureus , a metalloproteinase (aureolysin) and a glutamylendopeptidase (V8 protease). We found that aureolysin cleaved and inactivated LL-37 in a time- and concentration-dependent manner. Analysis of the generated fragments by mass spectroscopy revealed that the initial cleavage of LL-37 by aureolysin occurred between the Arg19-Ile20, Arg23-Ile24, and Leu31-Val32 peptide bonds, instantly annihilating the antibacterial activity of LL-37. In contrast, the V8 proteinase hydrolyzed efficiently only the Glu16-Phe17 peptide bond, rendering the C-terminal fragment refractory to further degradation. This fragment (termed LL-17-37) displayed antibacterial activity against S. aureus at a molar level similar to that of the full-length LL-37 peptide, indicating that the antibacterial activity of LL-37 resides in the C-terminal region. In keeping with LL-37 degradation by aureolysin, S. aureus strains that produce significant amounts of this metalloprotease were found to be less susceptible to LL-17-37 than strains expressing no aureolysin activity. Taken together, these data suggest that aureolysin production by S. aureus contributes to the resistance of this pathogen to the innate immune system of humans mediated by LL-37.

24 August 2017 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
JPJan Potempa
Jan Potempa
PMPiotr Mydel
Piotr Mydel
JKJoanna Koziel
Joanna Koziel


26 May 2017 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
AŁAnna Maria Łasica
Anna Maria Łasica
MKMiroslaw Ksiazek
Miroslaw Ksiazek
MMMariusz Madej
Mariusz Madej
JPJan Potempa
Jan Potempa
Protein secretion systems are vital for prokaryotic life, as they enable bacteria to acquire nutrients, communicate with other species, defend against biological and chemical agents, and facilitate disease through the delivery of virulence factors. In this review, we will focus on the recently discovered type IX secretion system (T9SS), a complex translocon found only in some species of the Bacteroidetes phylum. T9SS plays two roles, depending on the lifestyle of the bacteria. It provides either a means of movement (called gliding motility) for peace-loving environmental bacteria or a weapon for pathogens. The best-studied members of these two groups are Flavobacterium johnsoniae, a commensal microorganism often found in water and soil, and Porphyromonas gingivalis, a human oral pathogen that is a major causative agent of periodontitis. In P. gingivalis and some other periodontopathogens, T9SS translocates proteins, especially virulence factors, across the outer membrane (OM). Proteins destined for secretion bear a conserved C-terminal domain (CTD) that directs the cargo to the OM translocon. At least 18 proteins are involved in this still enigmatic process, with some engaged in the post-translational modification of T9SS cargo proteins. Upon translocation across the OM, the CTD is removed by a protease with sortase-like activity and an anionic LPS is attached to the newly formed C-terminus. As a result, a cargo protein could be secreted into the extracellular milieu or covalently attached to the bacterial surface. T9SS is regulated by a two-component system; however, the precise environmental signal that triggers it has not been identified. Exploring unknown systems contributing to bacterial virulence is exciting, as it may eventually lead to new therapeutic strategies. During the past decade, the major components of T9SS were identified, as well as hints suggesting the possible mechanism of action. In addition, the list of characterized cargo proteins is constantly growing. The actual structure of the translocon, situated in the OM of bacteria, remains the least explored area; however, new technical approaches and increasing scientific attention have resulted in a growing body of data. Therefore, we present a compact up-to-date review of this topic.